Open Journal of Blood Diseases
Vol.4 No.1(2014), Paper ID 43869, 8
pages
DOI:10.4236/ojbd.2014.41001
Reinduction Chemotherapy with Gemtuzumab Ozogamicin and Intermediate/High-Dose Cytarabine: A Single-Center Experience
Sohsuke Meshitsuka, Mitsuo Hori, Shoichi Mitsuhashi, Yasushi Okoshi, Hiroshi Kojima
Department of Clinical Oncology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
Department of Hematology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
Department of Clinical Oncology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
Department of Hematology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan;
Ibaraki Clinical Education and Training Center, University of Tsukuba Hospital, Ibaraki, Japan
Department of Clinical Oncology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
Copyright © 2014 Sohsuke Meshitsuka, Mitsuo Hori, Shoichi Mitsuhashi, Yasushi Okoshi, Hiroshi Kojima et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Meshitsuka, S. , Hori, M. , Mitsuhashi, S. , Okoshi, Y. and Kojima, H. (2014) Reinduction Chemotherapy with Gemtuzumab Ozogamicin and Intermediate/High-Dose Cytarabine: A Single-Center Experience.
Open Journal of Blood Diseases,
4, 1-8. doi:
10.4236/ojbd.2014.41001.